According to NHS data, approximately 28% of UK adults are living with obesity, creating significant demand for accessible weight management solutions
Although weight-loss specific drugs are now licensed, supply is limited, and as a consequence, off-label prescribing of diabetic drugs has continued to grow (particularly of Ozempic (active ingredient: semaglutide) and Mounjaro (active ingredient: tirzepatide))
FIGURE 4 4 Discussion AIs, categorized as nonsteroidal and steroidal, are widely used as adjuvant therapy and represent the gold standard for estrogen receptor (ER)+ BC management
Do Weight Loss Injections Cause Diarrhoea
However, customers remain responsible for reviewing the details supplied and deciding whether they wish to proceed with an order
Phenotypic assessment included estrous cycle monitoring, ovarian histology, and serum hormone profiling